eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community


All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   o   Check drugs   o   Compare drugs   o   Report a side effect
Join a support group   o   Ask a question   o   Write a review   o   Answered/ Unanswered   o   Reviews

Review: taking Singulair and Neurontin together

Summary: drug interactions are reported among people who take Singulair and Neurontin together.

This review analyzes the effectiveness and drug interactions between Singulair and Neurontin. It is created by eHealthMe based on reports of 2,064 people who take the same drugs from FDA and social media, and is updated regularly.

 

You are not alone: join a support group for people who take Singulair and Neurontin >>>

On Mar, 5, 2015: 2,064 people who take Singulair, Neurontin are studied

Singulair, Neurontin outcomes

Drug combinations in study:
- Singulair (montelukast sodium)
- Neurontin (gabapentin)

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Singulair is effectiven/a9.09%
(1 of 11 people)
50.00%
(3 of 6 people)
80.00%
(8 of 10 people)
45.45%
(5 of 11 people)
77.78%
(7 of 9 people)
71.43%
(5 of 7 people)
100.00%
(1 of 1 people)
Neurontin is effective25.00%
(1 of 4 people)
10.00%
(1 of 10 people)
50.00%
(2 of 4 people)
18.18%
(2 of 11 people)
72.73%
(8 of 11 people)
46.15%
(6 of 13 people)
0.00%
(0 of 1 people)
0.00%
(0 of 1 people)

Drug effectiveness by gender :

FemaleMale
Singulair is effective60.98%
(25 of 41 people)
35.71%
(5 of 14 people)
Neurontin is effective39.02%
(16 of 41 people)
28.57%
(4 of 14 people)

Drug effectiveness by age :

0-12-910-1920-2930-3940-4950-5960+
Singulair is effectiven/a0.00%
(0 of 1 people)
n/a26.32%
(5 of 19 people)
22.22%
(6 of 27 people)
23.08%
(9 of 39 people)
44.44%
(4 of 9 people)
26.09%
(6 of 23 people)
Neurontin is effectiven/a100.00%
(1 of 1 people)
n/a5.56%
(1 of 18 people)
3.70%
(1 of 27 people)
18.37%
(9 of 49 people)
22.22%
(2 of 9 people)
26.09%
(6 of 23 people)

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
DizzinessNauseaDepressionHypersensitivityMigraineDepressionEdema - Peripheral, Peripheral EdemaPain
Orthostatic HypotensionCoughAbnormal Behaviour NosNeuropathy PeripheralConvulsionSuicide AttemptAtrial FibrillationNausea
NauseaVomitingAggressionDeep Vein ThrombosisAnxietyAsthmaCoughDyspnoea
SomnolenceAbdominal Pain AggravatedShortness Of BreathPain In ExtremityIntentional OverdoseAnxietyShortness Of BreathAnxiety
FallDizzinessCoughCholelithiasisDizzinessFatigueAsthmaChest Pain
Balance DisorderInsomniaPainDrug IneffectiveDepressionIntentional OverdoseSaliva Alcohol Test PositiveDizziness
MalaiseDiverticulitisAngerSinus DisorderSuicide AttemptEdema - Peripheral, Peripheral EdemaFrequent HeadachesArthralgia
Thinking AbnormalIntestinal ObstructionCondition AggravatedPain - JointsDisturbance In AttentionLoss Of ConsciousnessExhaustion, Fatigue, Lethargy, Tiredness, WearinessFall
Gastric DisorderPolypPalmar-plantar Erythrodysaesthesia SyndromeAnxiety AggravatedCondition AggravatedDeep Vein ThrombosisNosebleedPneumonia
Mental Status ChangesAbdominal Pain UpperDiarrhoeaNosebleedHypersensitivityPulmonary EmbolismObsessive ThoughtsDrug Ineffective

Most common drug interactions by gender * :

FemaleMale
PainAnxiety
NauseaPain
DyspnoeaPneumonia
FallHeadache
Drug IneffectiveAnaemia
ArthralgiaChronic Obstructive Pulmonary Disease
DizzinessNeuropathy Peripheral
Chest PainBack Pain
VomitingChest Pain
AnxietyDizziness

Most common drug interactions by age * :

0-12-910-1920-2930-3940-4950-5960+
Orthostatic HypotensionApplication Site UrticariaMigraineDyspnoeaAnxietyPainPainDyspnoea
Pulmonary HypertensionConvulsionConvulsionNeuropathy PeripheralAbdominal PainChest PainFallPain
BronchospasmNauseaBenign Intracranial HypertensionLung DisorderType 2 Diabetes MellitusDrug IneffectiveAnxietyPneumonia
ConvulsionApplication Site PainSinus DisorderLymphadenopathyNauseaAsthmaNauseaBack Pain
Urinary Tract InfectionApplication Site IrritationSeborrhoeic DermatitisLacrimation IncreasedDyspnoeaNauseaDizzinessDizziness
SepsisCardiac ArrestHeadacheImpetigoPainHeadachePyrexiaAsthenia
NephrolithiasisAdenovirus Test PositivePainHodgkin's DiseaseHypersensitivityNephrogenic Systemic FibrosisArthralgiaChronic Obstructive Pulmonary Disease
Pericardial EffusionHypertensionDyspnoeaOral HerpesDiabetes MellitusOedema PeripheralChest PainNausea
Chest PainRespiratory FailureWeight IncreasedKeratoconjunctivitis SiccaOedema PeripheralAstheniaPain In ExtremityArthralgia
Type 2 Diabetes MellitusRenal FailureElectrocardiogram Qt ProlongedPneumothoraxPulmonary EmbolismVomitingInjuryDiarrhoea

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Singulair and Neurontin?

 

 

 

You are not alone! Join a related support group:
- support group for people who take Neurontin
- support group for people who take Singulair

Recent related drug studies (Check your drugs):

Complete drug side effects:

On eHealthMe, Singulair (montelukast sodium) is often used to treat asthma. Neurontin (gabapentin) is often used to treat pain. Find out below the conditions the drugs are used for, how effective they are, and any alternative drugs that you can use to treat those same conditions.

What is the drug used for and how effective is it:

Other drugs that are used to treat the same conditions:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.